Rituximab plus chemotherapy improved survival in mantle cell lymphoma HemOncToday Adding rituximab to standard chemotherapy results in an improvement in OS among older patients with mantle cell lymphoma, results of an observational study indicated. Although rituximab is known to improve survival for non-Hodgkin's lymphoma and ... |
